Prognostic Significance of Systemic Immune-Inflammation Index in Patients with de Novo non‑M3 Acute Myeloid Leukemia
SII is an independent prognostic marker in de novo non-M3 AML. The proposed nomogram, incorporating both SII and established prognostic variables, enables precise and individualized survival prediction. This tool has the potential to inform risk-adapted treatment strategies and guide decision-making in clinical practice.
Authors
- Mingyue Shi (ORCID: https://orcid.org/0000-0002-7896-0912)
- Yanliang Bai
- Fangfang Xu (ORCID: https://orcid.org/0000-0003-1364-7930)
- Yuanyuan Liu (ORCID: https://orcid.org/0000-0002-2873-8854)
- Fei Huang (ORCID: https://orcid.org/0000-0001-9665-6642)
- Wenqian Li (ORCID: https://orcid.org/0000-0003-3073-1667)
- Lijie Wang (ORCID: https://orcid.org/0000-0001-8674-3128)
- Huijie Nan (ORCID: https://orcid.org/0009-0004-0890-2647)
- Peiyao Yang (ORCID: https://orcid.org/0009-0002-6990-0181)
Institutions
- Handan College (CN)
- Henan Provincial People's Hospital (CN)
- Zhengzhou People's Hospital (CN)
Publication Details
- Journal
- Journal of Inflammation Research
- Published
- 2025-11-01
- DOI
- https://doi.org/10.2147/jir.s552797
- Primary Topic
- Acute Myeloid Leukemia Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00